Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.63 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.63 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.63 |
| ▸ | TLR2 | O60603 | 5/20 | 0.52 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.51 |
| ▸ | RRM1 | P23921 | 1/20 | 0.50 |
| ▸ | TERT | O14746 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20980426 | 1.00 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL24379775 | 1.00 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14240492 | 0.98 | GNAI3 (0.61) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL20980377 | 0.95 | GNAI3 (0.56) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL28990465 | 0.94 | GNAI3 (0.57) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14616487 | 0.93 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14616486 | 0.93 | GNAI3 (0.68) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL17886110 | 0.92 | GNAI3 (0.58) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14239755 | 0.92 | GNAI3 (0.55) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14916812 | 0.92 | GNAI3 (0.55) | GNAI3GNAO1GNAI1TLR2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | NITTO DENKO CORPORATION (JP) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | FUS, NSF, PGF | GNAI3 2204/4885GNAO1 2648/4885GNAI1 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.